Account
TCL appoints Vizeum as AOR; account size Rs 35 cr
MUMBAI: Vizeum, the media agency from Dentsu Aegis network, has been appointed as the Media AOR for TCL Corporation. The agency won the account following a multi-agency pitch. It is estimated that TLC’s marketing spends will be around Rs.35 Crores.
TCL Corporation, a global corporate group focused on the production of smart products and the provision of online application services, has announced its entry into the Indian market with the launch of a range of Smartphones and Televisions through an exclusive tie up with Amazon.
Commenting on the partnership with Vizeum, TCL regional director Praveen Valecha said, “The agency has demonstrated deep understanding of the categories, with an offline and online integration for the launch, and we believe their ‘digital at its heart’ approach will help us in building a brand we look forward to partner with Vizeum in this journey of launching a comprehensive mobile and Television portfolio.”
Vizeum COO Amita Karwal on the partnership with TCL said, “Delighted to be given an opportunity to build a brand in a category where the market and consumer dynamics are changing continuously. We look forward to supporting the brand across all the marketing communication platforms.”
Vizeum MD Shripad Kulkarni added, “We are happy that TCL has chosen us as their AOR. We understand the challenges in scaling up in this category and are setting up a bespoke team comprising specialists across relevant Communication Platforms for TCL.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
